Format

Send to

Choose Destination
See comment in PubMed Commons below
Prog Cardiovasc Dis. 2012 May-Jun;54(6):493-7. doi: 10.1016/j.pcad.2012.03.006.

Development of an entirely subcutaneous implantable cardioverter-defibrillator.

Author information

1
Arrhythmia and Electrophysiology Center, IRCCS Policlinico San Donato, Milan, Italy.

Abstract

The recent advent of an entirely subcutaneous implantable defibrillator (ICD) has provided a relevant contribution to the debate concerning the use of ICD therapy in patients at high risk for death. Although conventional transvenous ICDs have proven very effective during the past 23 years, they still appear to be limited by nontrivial acute and long-term complications. This study delineates some of the historical and current issues characterizing the advent of the subcutaneous ICD system in daily clinical practice. Subcutaneous ICDs have proven effective in more than 1100 patients worldwide and appear to be competitive with transvenous ICD in all clinical conditions not requiring antibradycardia, antitachycardia, or cardiac resynchronization pacing.

PMID:
22687590
DOI:
10.1016/j.pcad.2012.03.006
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center